Disorders of Growth

73 Disorders of Growth



Statural growth is an integral part of childhood development and normally occurs in a predictable pattern. Families often seek medical attention when a child does not seem to grow adequately, and the pediatrician’s primary responsibility is to differentiate between normal variants of growth and abnormal patterns (i.e., between a healthy petite child and a child with an underlying systemic illness or other growth problem). Because early detection is important for diagnosing any underlying illness and intervening to maximize potential adult height, interval growth should be accurately assessed and plotted on a growth chart at each health maintenance visit. When judging a child’s growth, it is useful to determine the sex-adjusted midparental height (genetic target height) by adding together the heights of the biological parents and adding 5 inches (13 cm) for a boy or subtracting 5 inches (13 cm) for a girl and then dividing by 2. This height, plus or minus approximately 4 inches, represents an estimate of the child’s genetic height potential. Any deviations from normal growth patterns or the child’s genetic height potential should be evaluated; the more the child’s growth deviates from the usual pattern, the greater the chances of an underlying abnormality.



Etiology and Pathogenesis




Longitudinal Growth and Mediating Factors


Longitudinal growth occurs via chondrocyte proliferation and subsequent endochondral ossification in the growth plates of long bones (and vertebrae). The growth plate is a cartilaginous zone located between the metaphysis and epiphysis (secondary ossification zone at the end of the bone). Growth is a complex process regulated by multiple factors, including nutrition, hormones, and growth factors that act either locally within the growth plate or systemically.


Growth hormone (GH) is the most important growth-regulating hormone; its pulsatile secretion from the anterior pituitary somatotrophs is regulated by two hypothalamic peptide hormones, GH-releasing hormone (GHRH) and somatostatin, which, respectively, stimulate and inhibit its release (Figure 73-1). Circulating GH is bound to GH-binding protein (GHBP), which corresponds to the extracellular domain of the GH receptor. Many, although not all, of GH’s actions are mediated through insulin-like growth factor (IGF)-I (i.e., somatomedin-C). Serum IGF-I is produced principally in the liver in response to GH and circulates in the bloodstream bound to IGF-binding proteins (especially IGFBP-3) that control its bioavailability. IGF-I acts at target tissues by binding cell-surface IGF receptors and triggering multiple downstream effects that include cellular hypertrophy and proliferation. IGF-I and free fatty acids also inhibit GH secretion at the level of the pituitary and hypothalamus.



Other systemic hormones that affect growth include insulin (the principal growth-promoting hormone in utero), androgens and estrogens (which induce the pubertal growth spurt and, in the case of estrogens, epiphyseal fusion), thyroid hormone (which has a permissive effect on GH secretion and exerts direct action at the growth plates), and glucocorticoids (which inhibit growth both centrally and at the growth plate).




Clinical Presentation


The causes of short stature can be divided into three general categories: chronic disease (including undernutrition), familial short stature (FSS), and constitutional delay of growth and puberty (CDGP) (Figure 73-2). Endocrine diseases are rare causes of short stature and are distinguished from other causes of short stature by linear growth failure that is more significant than weight loss. In developed countries, most short children have FSS, constitutional growth delay, or both. Short stature and constitutional growth delay are diagnoses of exclusion. The following is a focused review of the clinical presentations of selected normal variants and causes of short stature; see Box 73-1 for a comprehensive list of growth disorders.




Box 73-1 Differential Diagnosis of Short Stature




II Abnormal causes







Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Disorders of Growth

Full access? Get Clinical Tree

Get Clinical Tree app for offline access